WO2003025177A3 - Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments - Google Patents
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments Download PDFInfo
- Publication number
- WO2003025177A3 WO2003025177A3 PCT/IB2002/004523 IB0204523W WO03025177A3 WO 2003025177 A3 WO2003025177 A3 WO 2003025177A3 IB 0204523 W IB0204523 W IB 0204523W WO 03025177 A3 WO03025177 A3 WO 03025177A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tumour
- adoptosis
- viruses
- resistance
- reversion
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 5
- 241000700605 Viruses Species 0.000 title abstract 2
- 230000001629 suppression Effects 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000012472 biological sample Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003990 molecular pathway Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La présente invention concerne notamment de nouvelles séquences impliquées dans les voies moléculaires de la suppression tumorale, la réversion tumorale, l'apoptose et/ou la résistance aux virus. Elle concerne également l'utilisation de ces séquences ou le traitement contre le cancer, maladies virales, maladies neurodégénératives ainsi qu'en matière de diagnostique ainsi que pour la mise en oeuvre de procédés de criblage de composés à tester. Cette invention a également pour objet des procédés de détection et/ou de dosage des séquences de l'invention ou de leurs produits d'expression dans un prélèvement biologique.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR01/11980 | 2001-09-17 | ||
FR0111980 | 2001-09-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003025177A2 WO2003025177A2 (fr) | 2003-03-27 |
WO2003025177A3 true WO2003025177A3 (fr) | 2004-05-27 |
Family
ID=8867344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2002/004523 WO2003025177A2 (fr) | 2001-09-17 | 2002-09-17 | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2003025177A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7943308B2 (en) * | 2004-06-23 | 2011-05-17 | Epigenomics Ag | Methods and nucleic acids for the detection of metastasis of colon cell proliferative disorders |
CA2745811C (fr) * | 2008-12-04 | 2021-07-13 | Joseph Collard | Traitement de maladies liees a un gene suppresseur de tumeur par inhibition d'un transcrit antisens naturel du gene |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997022695A2 (fr) * | 1995-12-20 | 1997-06-26 | Fondation Jean Dausset-Ceph | Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer |
WO2000008147A1 (fr) * | 1998-08-05 | 2000-02-17 | Molecular Engines Laboratories | Genes impliques dans les voies moleculaires de la suppression tumorale et/ou la resistance aux virus |
FR2820757A1 (fr) * | 2001-02-13 | 2002-08-16 | Molecular Engines Lab | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicamments |
WO2003004526A2 (fr) * | 2001-06-20 | 2003-01-16 | Molecular Engines Laboratories | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments |
-
2002
- 2002-09-17 WO PCT/IB2002/004523 patent/WO2003025177A2/fr not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997022695A2 (fr) * | 1995-12-20 | 1997-06-26 | Fondation Jean Dausset-Ceph | Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer |
WO2000008147A1 (fr) * | 1998-08-05 | 2000-02-17 | Molecular Engines Laboratories | Genes impliques dans les voies moleculaires de la suppression tumorale et/ou la resistance aux virus |
FR2820757A1 (fr) * | 2001-02-13 | 2002-08-16 | Molecular Engines Lab | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicamments |
WO2002064731A2 (fr) * | 2001-02-13 | 2002-08-22 | Molecular Engines Laboratories | Sequences impliquees dans les phenomenes de suppression tumorale reversion tumorale apoptose et/ou resistance aux virus et leur utilisation comme medicaments |
WO2003004526A2 (fr) * | 2001-06-20 | 2003-01-16 | Molecular Engines Laboratories | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments |
Non-Patent Citations (8)
Title |
---|
BRENNER ET AL.: "Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays", NATURE BIOTECHNOLOGY, vol. 18, June 2000 (2000-06-01), pages 630 - 634, XP002199492 * |
DATABASE EM_EST [online] EMBL; 18 February 1996 (1996-02-18), HILLIER ET AL.: "yv31d01.s1 Soares fetal liver spleen 1NFLS Homo sapiens cDNA clone IMAGE:244321 3' similar to gb:M31627 X BOX BINDING PROTEIN-1 (HUMAN);, mRNA sequence", XP002238234, retrieved from EBI accession no. HS802292 Database accession no. N54802 * |
DATABASE EM_EST [online] EMBL; 18 November 1992 (1992-11-18), OKUBO ET AL.: "Human HepG2 3'-directed MboI cDNA, clone hm02d10", XP002238235, retrieved from EBI accession no. HSHM02D10 Database accession no. D11831 * |
DATABASE EM_EST [online] EMBL; 19 November 1998 (1998-11-19), NCI-CGAP: "qt93f02.x1 NCI_CGAP_Co14 Homo sapiens cDNA clone IMAGE:1962843 3' similar to gb:M31627 X BOX BINDING PROTEIN-1 (HUMAN);, mRNA sequence", XP002238233, retrieved from EBI Database accession no. AI270738 * |
DATABASE EM_PAT [online] EMBL; 24 October 2002 (2002-10-24), TELERMAN ET AL.: "Sequence 611 from patent WO02064731", XP002238236, retrieved from EBI Database accession no. AX522941 * |
GENOME RES, vol. 6, no. 9, 1996, pages 807 - 828, XP000914615 * |
NAT GENET, vol. 2, 1992, pages 173 - 179, XP002913265 * |
ROPERCH JEAN-PIERRE ET AL: "SIAH-1 promotes apoptosis and tumor suppression through a network involving the regulation of protein folding, unfolding, and trafficking: Identification of common effectors with p53 and p21Waf1", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 96, no. 14, 6 July 1999 (1999-07-06), pages 8070 - 8073, XP002182373, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003025177A2 (fr) | 2003-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Swystun et al. | Breast cancer chemotherapy induces the release of cell‐free DNA, a novel procoagulant stimulus | |
WO2005014035A3 (fr) | Utilisation de galactose oxydase pour la conjugaison chimique selective de molecules d'extraction a des proteines d'interet therapeutique | |
WO2002056022A3 (fr) | Marqueurs tumoraux de diagnostic, analyse de medicaments pour l'inhibition de la tumorigenese, et compositions et procedes pour le traitement du cancer | |
WO2004066941A3 (fr) | Profils d'expression destines au cancer du colon et procedes d'utilisation | |
WO2004075823A3 (fr) | Derives de benzimidazole et d’imidazo-pyridine ayant une addinite pour les recepteurs des melanocortines et leur utilisation en tant que medicament | |
WO2005067391A3 (fr) | Test de diagnostic de la maladie de parkinson | |
WO2005059108A3 (fr) | Profils d'expression geniques et procedes d'utilisation | |
WO2004089951A8 (fr) | Derives d’imidazo-pyridine ayant une affinite sur des recepteurs de la melanocortine | |
WO2004106495A3 (fr) | Compositions, kits et procedes d'identification, d'evaluation et de prevention, et therapie anticancereuse | |
WO2003087831A3 (fr) | Proteines impliquees dans le cancer du sein | |
WO2004067570A3 (fr) | Diagnostic et traitement du cancer de la prostate | |
WO2003016464A3 (fr) | Sequences d'oligosaccharides specifiques pour le cancer et leur utilisation | |
WO2007058968A3 (fr) | Profils d’expression genique et procedes d’utilisation | |
WO2005032495A8 (fr) | Profils d'expression genique et leurs methodes d'utilisation | |
WO2004078035A3 (fr) | Profiles d'expression pour le cancer du sein et methodes d'utilisation | |
WO2004046332A3 (fr) | Genes amplifies impliques dans un cancer | |
WO2005005661A3 (fr) | Genes regules dans le cancer de l'ovaire utilises comme cibles pronostique et therapeutique | |
WO2005000335A3 (fr) | Procedes de diagnostic et de traitement lies au vieillissement, en particulier au vieillissement du foie | |
WO2005014846A3 (fr) | Procedes pour reperer le risque de cancer du sein et traitements correspondants | |
WO2003102185A3 (fr) | Procedes et compositions pour traiter une neoplasie associee aux molecules d'acides nucleiques de a1 et a2 de hnrnp | |
WO2003040369A3 (fr) | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments | |
WO2002064731A3 (fr) | Sequences impliquees dans les phenomenes de suppression tumorale reversion tumorale apoptose et/ou resistance aux virus et leur utilisation comme medicaments | |
WO2003025177A3 (fr) | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments | |
WO2003025176A8 (fr) | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments | |
WO2003025175A3 (fr) | Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FR GB GR IE IT LU MC NL PT SE SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |